Amrutanjan Health Care share price

Balanced risk
  • 33%Low risk
  • 33%Moderate risk
  • 33%Balanced risk
  • 33%High risk
  • 33%Extreme risk
  • ₹668.00(-2.39%)
    April 23, 2025 15:28:00 PM IST
    • NSE
    • BSE
  • Vol : 13.93K (NSE + BSE)
    Last 20 day avg : 38.41 K

Amrutanjan Health Care is trading -2.39% lower at Rs 668.00 as compared to its last closing price. Amrutanjan Health Care has been trading in the price range of 686.00 & 666.75. Amrutanjan Health Care has given -7.26% in this year & 0.10% in the last 5 days. Amrutanjan Health Care has TTM P/E ratio 42.39 as compared to the sector P/E of 31.53.The company posted a net profit of 19.25 Crores in its last quarter.Listed peers of Amrutanjan Health Care include Vimta Labs (6.90%), Novartis India (0.87%), Amrutanjan Health Care (-2.39%).The Mutual Fund holding in Amrutanjan Health Care was at 9.21% in 31 Dec 2024. The MF holding has decreased from the last quarter. The FII holding in Amrutanjan Health Care was at 2.30% in 31 Dec 2024. The FII holding has decreased from the last quarter.

  • Overview
  • Financials
  • Forecast
  • Technical Analysis
  • Peers
  • Shareholding
  • About the company
  • FAQ

Overview

  • 1 D
  • 5 D
  • 1 M
  • 3 M
  • 6 M
  • 1 Y
  • 5 Y
  • MAX
Key Metrics

Updated on Apr 24, 2025, 01:32 AM UTC

  • Dividend Yield
    Annual dividends as a percentage of the stock price.
    0.69
    Lower than industry
  • P/B
    The P/B ratio shows how a stock's market price compares to its book value. It helps gauge whether a stock is undervalued or overvalued relative to its net assets.
    6.72
    In line with historical values
  • P/E
    Price-to-earnings ratio based on trailing 12-month earnings
    39.31
    Lower than historical values
  • Beta
    Beta measures a stock's volatility compared to the overall market. A beta > 1 indicates higher volatility than the market.
    1.05
    Medium volatility
  • Debt To Equity
    The debt-to-equity ratio, indicating a company's financial leverage.
    0.01
    In line with industry
  • PEG Ratio
    The PEG ratio evaluates a stock's valuation by comparing its P/E ratio to its earnings growth rate. A lower PEG suggests better value relative to growth
    -
Price range
Day Range
Lowest
666.75
Highest
686.00
52 week range
Lowest
548.05
Highest
861.40
Amrutanjan Health Care News
Amrutanjan Health Care Financials
Financials
Financials include key reports like the Profit & Loss Statement (P&L), Balance Sheet, and Cash Flow Statement, providing insights into a company's performance, financial health, and liquidity
View all
  • Income
  • Balance Sheet
  • Cash Flow
Loading...
Units in the chart are in crores
Insights
  • Financial
  • Valuation
    • financial-insightsCompany is profitable
    • financial-insightsThe company's revenue grew in December quarter by 4.92% from Rs 122.75 crore to Rs 116.99 crore, year-on-year
    • financial-insightsThe company has grown its December quarter profit by 10.29% from Rs 17.45 crore to Rs 19.25 crore, year-on-year
    • financial-insightsThe debt to equity of the company is lower than the industry median
    • financial-insightsCompany can comfortably pay off its interest obligations with its earnings
Amrutanjan Health Care Technical Analysis
Pivot Level - classic
Info
Key price levels (support and resistance) calculated using the previous day's high, low, and close, aiding in technical analysis and trading decisions
  • R1
  • 725.05
  • R2
  • 805.25
  • R3
  • 882.50
Pivot647.80
  • S1
  • 567.60
  • S2
  • 490.35
  • S3
  • 410.15
Short Term
Info
Considers price movement over the last 1-2 weeks
Not Available
Long Term
Info
Considers price movement over the last 6 months
Not Available
  • Very Bearish
  • Bearish
  • Neutral
  • Very Bullish
  • Bullish
Trends unavailable at the moment.
Amrutanjan Health Care Peers
Return Comparison
Peers Comparison
Names
Technical ratingPrice%ChangeMarket CapP/EP/BDividend YieldDebt to Equity
Vimta Labs
Bullish
1,049.006.902,355.9155.426.940.202.84
Novartis India
Neutral
847.000.872,085.7025.562.782.980.68
Amrutanjan Health Care
Neutral
668.00-2.391,947.7043.046.750.680.48
Bajaj Healthcare
Bullish
626.001.811,977.11163.546.080.1614.06
Sms Pharmaceuticals
Moderately Bullish
240.1011.702,032.4936.893.430.1822.76
Amrutanjan Health Care Shareholding
View All
Shareholding Pattern
Breakdown of a company's ownership structure, showing stakes held by Promoters, Mutual Funds, FII(s) & Others.
    No Data
    Shareholding pattern for Amrutanjan Health Care is currently unavailable
    Please check back later.
    Shareholding Insights
    • InsightsPromoter(s) holding is moderate at 46.52%
    • InsightsPromoter(s) have decreased the stake in the company in last 12 months
    • InsightsFIIs are invested in this company
    • InsightsFIIs holding has decreased by 0.04 percentage points from previous quarter
    • InsightsMutual Funds holding is constant over the last quarter at 9.21%
    Mutual Fund Ownership
    View all
    ICICI Prudential FMCG Fund Growth
    NA
    • Amount Invested (Cr.) 46.55
    • % of AUM 2.51
    DSP Small Cap Fund Regular Plan Growth
    3/5
    • Amount Invested (Cr.) 95.62
    • % of AUM 0.67
    Amrutanjan Health Care Corporate Actions
    View all
    • Board Meetings
    • AGM
    • Dividends
    • Bonus
    • Split
    • Rights
    Meeting DatePurpose
    2025-02-12Quarterly Results & Interim Dividend
    2024-11-12Quarterly Results & Interim Dividend
    2024-08-13Quarterly Results
    2024-05-23Audited Results & Final Dividend
    2024-02-09Quarterly Results & Interim Dividend
    About the company Amrutanjan Health Care
    • IndustryBiotechnology & Drugs
    • ISININE098F01031
    • BSE Code590006
    • NSE CodeAMRUTANJAN
    Amrutanjan Health Care Limited is an India-based company, which is engaged in the business of manufacturing, supplying and sale of products in pain management, congestion management, beverages, and hygiene and services in pain management. Its segments include OTC Products, Women Hygiene, Beverages and Others. The OTC Products segment is engaged in manufacturing products for pain management, congestion management and hygiene. The Women Hygiene includes Comfy Snug Fit, Comfy Snug Fit Extra Long, and Comfy Snug Fit Ultra XL. The Beverages segment is engaged in manufacturing fruit juices and oral hydration drinks. The Others segment includes the pain management center. The Company’s pain management products include Pain Balm Extra Power, Strong Pain Balm, New Maha Strong Pain Balm, Roll on and Advanced Back Pain + Roll-On, among others. Its congestion management products include Relief Cold Rub, Relief Nasal Inhaler, Relief Cough Syrup and Relief Swas Mint.
    • Management Info
    • S. Sambhu PrasadExecutive Chairman of the Board, Managing Director
    • N. SwaminathanChief Financial Officer
    • Mani BhagavatheeswaranChief Marketing Officer
    • M. SrinivasanCompliance Officer, Company Secretary
    • Soumomoy PalGeneral Manager - Information Technology
    • J. RavichandranGeneral Manager - QC/QA/R&D
    • S. JeyakanthChief Operating Officer - Supply Chain and Product Delivery
    • R. NarayananChief Sales Officer
    Amrutanjan Health Care Share Price FAQs

    Amrutanjan Health Care is trading at 668.00 as on Wed Apr 23 2025 09:58:00. This is -2.39% lower as compared to its previous closing price of 684.35.

    The market capitalization of Amrutanjan Health Care is 1947.70 Cr as on Wed Apr 23 2025 09:58:00.

    The 52 wk high for Amrutanjan Health Care is 861.40 whereas the 52 wk low is 548.05

    Amrutanjan Health Care can be analyzed on the following key metrics -

    • TTM P/E: 42.39
    • Sector P/E: 31.53
    • Dividend Yield: 0.69%
    • D/E ratio: -

    Amrutanjan Health Care reported a net profit of 44.97 Cr in 2024.

    The Mutual Fund Shareholding was 9.21% at the end of 31 Dec 2024.

    Quick Links
    EQUITY QUICK LINKS
    Amrutanjan Health Care QUICK LINKS
    FROM MARKETS
    RELATED LINKS
    Quarterly Results
    Business News/Market/Market Stats/   Amrutanjan Health Care share price

    Wait for it…

    Log in to our website to save your bookmarks. It'll just take a moment.